Medicare Enrolled

Dr. Karen Tinder, NP

Nurse Practitioner - Family · Walnut Creek, CA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
2637 SHADELANDS DR, Walnut Creek, CA 94598
9259456600
In practice since 2014 (11 years)
NPI: 1225442080 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Tinder from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Tinder? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Tinder

Dr. Karen Tinder is a nurse practitioner - family in Walnut Creek, CA, with 11 years of NPI registration. Based on federal Medicare data, Dr. Tinder performed 2,511 Medicare services across 659 unique beneficiaries.

Between the years covered by Open Payments, Dr. Tinder received a total of $11,158 from 48 pharmaceutical and/or device companies across 417 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in nurse practitioner - family. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Tinder is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 11 years in practice ▲ Top 6% volume in CA $11,158 industry payments

Medicare Practice Summary

Medicare Utilization ↗
2,511
Medicare services
Top 6% in CA for nurse practitioner - family
659
Unique beneficiaries
$30
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~228 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Denosumab injection (Prolia/Xgeva) 1,620 $16 $46
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
454 $67 $305
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
152 $52 $211
Electrocardiogram (EKG), 12-lead
A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report.
63 $9 $106
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
60 $11 $75
Annual wellness visit, follow-up
A follow-up annual wellness visit that includes a personalized prevention plan of service.
52 $48 $312
Flu vaccine administration
This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient.
23 $31 $70
Flu vaccine, quadrivalent
A flu shot containing four strains of the influenza virus to help prevent seasonal influenza infection.
22 $76 $127
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
18 $60 $308
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
18 $124 $461
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
15 $108 $406
Urinalysis, manual
A manual laboratory examination of a urine sample to check for various substances and cells.
14 $3 $19
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$11,158
Total received (2021-2024)
Avg $2,789/year across 4 years
Top 1% in CA for nurse practitioner - family
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
48
Companies
417
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$11,158 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$3,516
2023
$2,243
2022
$2,441
2021
$2,958

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Amgen Inc.
$1,132
Lilly USA, LLC
$451
Boehringer Ingelheim Pharmaceuticals, Inc.
$254
Novo Nordisk Inc
$221
Radius Health, Inc.
$154
Xeris Pharmaceuticals, Inc.
$150
Madrigal Pharmaceuticals
$143
Abbott Laboratories
$125
Mannkind Corporation
$113
Currax Pharmaceuticals LLC
$94
PFIZER INC.
$74
Ascensia Diabetes Care Us Inc.
$63
IBSA Pharma Inc.
$62
GlaxoSmithKline, LLC.
$60
Dexcom, Inc.
$55
Bayer Healthcare Pharmaceuticals Inc.
$51
AstraZeneca Pharmaceuticals LP
$45
ABBVIE INC.
$34
Alexion Pharmaceuticals, Inc.
$33
Vanda Pharmaceuticals Inc.
$31
Averitas Pharma Inc.
$25
Kyowa Kirin, Inc.
$24
Insulet Corporation
$24
SANOFI-AVENTIS U.S. LLC
$19
Optinose US, Inc.
$19
Antares Pharma, Inc.
$16
Bausch Health US, LLC
$16
Otsuka America Pharmaceutical, Inc.
$14
Lundbeck LLC
$13
Top 3 companies account for 52.2% of 2024 payments
All-time payments by company (2021-2024) ›
Novo Nordisk Inc
$2,530
Amgen Inc.
$1,509
Boehringer Ingelheim Pharmaceuticals, Inc.
$930
Lilly USA, LLC
$853
AstraZeneca Pharmaceuticals LP
$648
Corcept Therapeutics
$442
Radius Health, Inc.
$403
IBSA Pharma Inc.
$350
Xeris Pharmaceuticals, Inc.
$258
ABBVIE INC.
$235
GlaxoSmithKline, LLC.
$232
Bayer Healthcare Pharmaceuticals Inc.
$225
Abbott Laboratories
$221
Mannkind Corporation
$203
AbbVie Inc.
$175
Bayer HealthCare Pharmaceuticals Inc.
$163
Madrigal Pharmaceuticals
$143
MannKind Corporation
$130
Silk Road Medical, Inc.
$129
PFIZER INC.
$128
Currax Pharmaceuticals LLC
$123
SANOFI-AVENTIS U.S. LLC
$121
Janssen Pharmaceuticals, Inc
$102
Medtronic, Inc.
$91
Dexcom, Inc.
$86
Exact Sciences Corporation
$71
Supernus Pharmaceuticals, Inc.
$69
Ascensia Diabetes Care Us Inc.
$63
Alexion Pharmaceuticals, Inc.
$58
Insulet Corporation
$51
Tandem Diabetes Care, Inc.
$42
Bausch Health US, LLC
$38
CeQur Corporation
$37
Vanda Pharmaceuticals Inc.
$31
Ascendis Pharma Inc
$29
Embecta Corp.
$27
Averitas Pharma Inc.
$25
Kyowa Kirin, Inc.
$24
Astellas Pharma US Inc
$22
Corium, LLC
$22
Biohaven Pharmaceutical Holding Company Ltd.
$20
Optinose US, Inc.
$19
Antares Pharma, Inc.
$16
Amarin Pharma Inc.
$14
Otsuka America Pharmaceutical, Inc.
$14
Lundbeck LLC
$13
Clarus Therapeutics Inc.
$12
E.R. Squibb & Sons, L.L.C.
$12
Top 3 companies account for 44.5% of all-time payments
Associated products mentioned in payments ›
AFREZZA · APLENZIN · AZSTARYS · BAQSIMI · BD Nano 2nd Gen Pen Needle · BEXSERO · BREZTRI · CONTRAVE · CREON · CeQur Simplicity · Cologuard Collection Kit · Crysvita · Dexcom G6 Transmitter · ELIQUIS · EMGALITY · ENHANCE Transcarotid Peripheral Access Kit · EVENITY · EVERSENSE E3 SENSOR KIT - RETAIL · FARXIGA · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · GVOKE HYPOPEN · GVOKE PFS · HETLIOZ · JARDIANCE · JATENZO · Kerendia · Korlym · LICART · MINIMED 770G · MINIMED 780G · MOUNJARO · MYRBETRIQ · NURTEC ODT · OFEV · ONZETRA XSAIL · Omnipod · Otezla · Ozempic · PREVNAR 20 · QUTENZA · RETEVMO · REXULTI · REZDIFFRA · RYBELSUS · Repatha · Rybelsus · SHINGRIX · SKYTROFA · SOLIQUA 100/33 · SPIRIVA RESPIMAT · STRENSIQ · SYNTHROID · Saxenda · TEPEZZA · TOUJEO · TRULICITY · Tirosint · Tymlos · UBRELVY · Vascepa · Wegovy · XARELTO · XYOSTED · Xhance · ZEPBOUND · t:slim X2 Insulin Pump with Control-IQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 1% for nurse practitioner - family in CA.

Looking for a nurse practitioner - family in Walnut Creek?
Compare family nurse practitioners in the Walnut Creek area by procedure volume, costs, and industry payment transparency.
Browse family nurse practitioners nearby

Geographic Context

Family nurse practitioners within 10 mi
1,179
Per 100K population
101.5
County median income
$125,727
Nearest hospital
JOHN MUIR MEDICAL CENTER - WALNUT CREEK CAMPUS
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Tinder is a clinical cardiology specialist, with above-average Medicare volume (top 6% in CA), with low-engagement industry engagement in the top 1% of CA peers.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Tinder experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Tinder performed 1,620 denosumab injection (prolia/xgeva) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Tinder receive payments from pharmaceutical companies?
Yes. Dr. Tinder received a total of $11,158 from 48 companies across 417 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Tinder's costs compare to other family nurse practitioners in Walnut Creek?
Dr. Tinder's average Medicare payment per service is $30. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Tinder) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →